Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TORISEL® Principal Display Panel (temsirolimus)

PRINCIPAL DISPLAY PANEL - 25 mg/mL Vial Label

TORISEL®
(temsirolimus) injection

25 mg/mL*

*each vial contains 0.2 mL overfill
MUST BE DILUTED
10 mg/mL after initial dilution
Single Use - Refrigerate
Cytotoxic: Handle with caution

Rx only

LOT / EXP.:

PRINCIPAL DISPLAY PANEL - 25 mg/mL Vial Label

PRINCIPAL DISPLAY PANEL - 2.2 mL Vial Label

NDC 0008-1125-01
DILUENT
for TORISEL®

2.2 mL

Not for direct administration
Only for dilution of TORISEL
(temsirolimus) injection vial
Single Use - Refrigerate

LOT / EXP.:

PRINCIPAL DISPLAY PANEL - 2.2 mL Vial Label

PRINCIPAL DISPLAY PANEL - Kit Carton

NDC 0008-1179-01

Pfizer

TORISEL®Kit
(temsirolimus) injection

25 mg/mL*

*each vial contains 0.2 mL overfill

CONCENTRATED - Requires two dilutions
before administration

10 mg/mL after initial dilution
For intravenous infusion only

Each carton contains:
1 vial TORISEL® (temsirolimus) injection 25 mg/mL*
1 vial DILUENT for TORISEL®

Cytotoxic: Handle with caution

Refrigerate
Rx only

PRINCIPAL DISPLAY PANEL - Kit Carton
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event